Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Kombo

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
European Journal of Medicinal Chemistry|October 12, 2011
Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligandsDavid C Kombo, Anatoly Mazurov, Kartik Tallapragada, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR)David C Kombo, Terry A Hauser, Vladimir P Grinevich, et al.
Neuropharmacology|February 7, 2012
Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimineTerry A Hauser, Christopher D Hepler, David C Kombo, et al.
Journal of Medicinal Chemistry|November 7, 2012
Discovery of (2S,3R)-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a selective α7 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disordersAnatoly A Mazurov, David C Kombo, Terry A Hauser, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
European Journal of Medicinal Chemistry|October 12, 2011
Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligandsDavid C Kombo, Anatoly Mazurov, Kartik Tallapragada, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR)David C Kombo, Terry A Hauser, Vladimir P Grinevich, et al.
Neuropharmacology|February 7, 2012
Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimineTerry A Hauser, Christopher D Hepler, David C Kombo, et al.
Journal of Medicinal Chemistry|November 7, 2012
Discovery of (2S,3R)-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a selective α7 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disordersAnatoly A Mazurov, David C Kombo, Terry A Hauser, et al.
Pageof 2